Skip to search formSkip to main contentSkip to account menu

123I-IBZM

Known as: Iodine I 123 Iodobenzamide 
A radiopharmaceutical containing the dopamine D2/D3 receptor agonist iodobenzamide (IBZM) labeled with the radionuclide iodine I 123 with dopamine… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
2008
2008
Objective: 123I‐IBZM single photon emission computed tomography (SPECT) is a widely used method to measure D2 receptor… 
Review
2007
Review
2007
Dopamine D2 receptor scintigraphy of pituitary adenomas is feasible by single-photon emission computed tomography using (123)I-S… 
2004
2004
Most post-mortem autoradiographic studies have described striatal dopamine D2 receptor up-regulation due to chronic neuroleptic… 
2000
2000
Hallervorden-Spatz disease (HSD), a rare extrapyramidal motor illness with familial aggregation or sporadic appearance, is… 
Highly Cited
1998
Highly Cited
1998
We performed a prospective clinical follow up (mean follow up, 36 months; range, 24–56 months) of 65 patients with de novo… 
1997
1997
Abstract.This paper describes a novel technique for registering a dynamic sequence of single-photon emission tomography (SPET… 
Highly Cited
1993
Highly Cited
1993
Factors contributing to the quantification of the striatal dopamine D2 receptor binding potential in vivo using 123I… 
1993
1993
The purposes of this study are to evaluate the utility of kit formulation, the basicin vivo characteristics, and clinical…